L30- Future Treatment Flashcards

1
Q

Which drug which was for duchenne muscular dystrophy was studied for class 1 mutations (brodlie et Al 2015)

A

Ataluren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many have class 1 mutations

A

5-10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What did ataluren propose to do

A

Help ribosomes skip over the ptc due to the nonsense mutation class 1 in CFTR. This made a functional CFTR protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What was found in the first clinical trials

A

Increased expression of CFTR in basal epi cells when administered and no adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why was ataluren not marketed

A

In phase 3 found no fev1 change or sweat Cl in patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Modulators aren’t cures. What is

A

Gene therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the major issue with Gene therapy

A

The viral and non viral vectors can have issues when administered and sometimes not tolerated by body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a non viral vector example

A

Liposomes which are fat droplets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a good thing about then

A

When inhaled or nebulised spray they can easily be absorbed into the cell membrane and nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In what patients did fev increase in first trials with liposomes

A

Only with severe diseqse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why was it discontinued

A

Not as good as modulators and the fev1 showed fluctuation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which article discusses different vectors for gene therapy

A

Burnley 2012

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why was adenovirus not a good idea

A

Causes inflammation and toxicity signs in the clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why was adeno associated viruses AAV used instead but why did it fail

A

Less pathogenic but we’re too small to package the CFTR gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which type of virus was good because can target both non dividing and dividing cells

A

Lentiviruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What was the flaw with lentiviruses

A

Have no receptor they bind to in airways. Needed to be made from fusing another viruses ha and fusion protein

17
Q

Which 3 ways of gene editing are there

A

Talen - a re which is engineered to cleave specific sequence

Zfn nucleases

Crispr cas 9

18
Q

Grna and cas9 used to target and cleave dna but what does it depend on to rearrange the healthy gene in

A

HDR or NHEJ

19
Q

Why is mucociliary clearance strategies still neeedd

A

Still class 1,5 and 6 struggling

20
Q

Name some types

A

Hypertonic saline

Dornase Alfa

Inhaled mannitol

21
Q

What is dornase alfa

A

The DNase cleaving dna in mucus and sputum and reduces viscosity

22
Q

Which article discusses hypertonic saline

A

Elkins 2006

23
Q

What does hypertonic saline do

A

Increase fev and fvc

Reduced exacerbations too

Increased hydration of asl, transportation of sputum and cough induction

Without major cost or side effect

24
Q

Which enac channel inhibitor was promising found in ussing chamber ion movement

A

Spx-101

25
Q

What did it do in early clinical trials before seeing no lung function change in clinical phases

A

Showed increased mucociliary clearance and reduced inflammation in sheep

26
Q

Which cacc channel was found promising in ussing chamber experiments and what channel does it have

A

Tmem16a

Has a cl HCO exchanger (augments Cl release)

27
Q

Which drug Tmem16a made it through preclinical trials and why

A

Denufosol

Improved ciliary and mucociliary functions

28
Q

Why did clinical trials see no long term effect of denufosol

A

It’s a short acting channel compared to CFTR

29
Q

Which article discusses Tmem16a potentiation

A

Danahay et Al 2019

30
Q

How did denufosol work and had no long term effects

A

Bound to p2y2 receptors and increased ic calcium whcih triggered the tmem16a channel to release Cl

Ended up desensitising the receptor and depleting ca stores

31
Q

Why are other potnetiators being looked at for longer Tmem16a potentiation

A

Ones that increase the activation of tmem16a from already endogenous stimuli

32
Q

Which therapies are for anti inflam and infection

A

Ibuprofen and for infection eg azithromycin antibiotics